Nuvation Bio Inc., a global oncology company, is set to participate in the Cantor Global Healthcare Conference 2025 on Thursday, September 4, 2025, in New York, NY. The company's Founder, President, and CEO, David Hung, M.D., along with CFO Philippe Sauvage, will engage in a fireside chat at 2:10 p.m. ET. Live webcasts will be available on Nuvation Bio's Investor Relations website.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvation Bio Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250827012140) on August 27, 2025, and is solely responsible for the information contained therein.